Covid drug controversy, Lululemon bets big on Mirror, Federal Reserve update

Covid drug controversy, Lululemon bets big on...

Up next

12 PM MARKET MINUTE

12 PM MARKET MINUTE See acast.com/privacy for privacy and opt-out information. 

Records for bitcoin, stocks and U.S. debt; COVID headwinds for 2021; XRP woes mount

Records for bitcoin, stocks and U.S. debt; COVID headwinds for 2021; XRP woes mount See acast.com/privacy for privacy and opt-out information. 

Recommended Episodes

Fed, Jobs, Markets… And A Beaten Down Lululemon Reports Results 9/4/25
CNBC's "Fast Money"

The Federal Reserve’s independence in focus as the Justice Department opens a probe into Lisa Cook, and President Trump’s Fed board nominee Stephen Miran faces questions on the Hill. Plus The next stretch for Lululemon, as the retailer reports results. What the numbers mean fo ...

  Show more

Wildcard: A $500 Million Mirror
Industry Focus

Earlier this week, news broke that apparel brand Lululemon is buying Mirror, maker of a sleek, smart, home fitness device. The move connects a strong lifestyle brand and massive retail footprint with an upstart in a related and quickly growing category -- but does it make sense? ...  Show more

“Lulu, Lulu, on the wall” — Lululemon acquires Mirror. Uber may buy Postmates. Netflix’s $100M black bank bet.
The Best One Yet

Athleisure icon Lululemon splurges $500M to acquire Peloton-ish in-home workout startup Mirror. Fresh off its acquisition breakup with Grubhub, Uber is looking to rebound with Postmates instead. And Netflix will stream $100M of its cash into black community banks to fix the bank ...  Show more

Big Pharma Breakout… And A Billionaire Boycott On Netflix 10/1/25
CNBC's "Fast Money"

Pharma stocks breaking out, as President Trump inks a drug pricing deal. What it means for the group, and how the broader health care sector is breathing a sigh of relief. Plus Elon Musk and some bingeing backlash. Why the billionaire is calling for customers to cancel their s ...

  Show more